Economiic Home Method Watch Market RSI Search

Royalty Pharma plc RPRX

Sector:

Healthcare

Industry:

Biotechnology

Description:

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Royalty Pharma plc website

Recent Quarter:

2024-11-06

Upcoming Quarter:

2025-02-20

Annual Reports

Date2024-02-15
Revenue 2,354,554,000
Net Income 1,134,834,000
EPS 3.41
Basic Shares 447,601,000
Diluted Shares 602,900,000
Report Link
Date2023-02-15
Revenue 2,237,215,000
Net Income 42,832,000
EPS 0.0978
Basic Shares 437,963,000
Diluted Shares 437,972,000
Report Link
Date2022-02-15
Revenue 2,289,463,000
Net Income 478,754,000
EPS 1.15
Basic Shares 414,794,000
Diluted Shares 414,802,000
Report Link
Date2021-02-24
Revenue 2,122,000,000
Net Income 495,198,000
EPS 1.32
Basic Shares 375,444,000
Diluted Shares 375,455,000
Report Link
Date2019-12-31
Revenue 1,814,254,000
Net Income 2,348,535,000
EPS 6.42
Basic Shares 365,899,235
Diluted Shares 365,899,235
Report Link
Date2018-12-31
Revenue 1,794,894,000
Net Income 1,377,729,000
EPS 3.89
Basic Shares 354,175,555
Diluted Shares 354,175,555
Report Link
Date2017-12-31
Revenue 1,597,930,000
Net Income 1,210,025,000
EPS 3.42
Basic Shares 354,175,555
Diluted Shares 354,175,555
Report Link
Date2016-12-31
Revenue 1,877,410,000
Net Income 565,907,000
EPS 0.93
Basic Shares 607,035,230
Diluted Shares 607,035,230
Report Link
Date2015-12-31
Revenue 1,652,420,000
Net Income 581,426,000
EPS 0.96
Basic Shares 607,035,230
Diluted Shares 607,035,230
Report Link

Annual Ratios

Date2023-12-31
PE 11.08
Dividend Yield 2.85
Payout Ratio: 31.575%
Date2022-12-31
PE 404.10
Dividend Yield 1.93
Payout Ratio: 778.208%
Date2021-12-31
PE 34.53
Dividend Yield 1.73
Payout Ratio: 59.568%
Date2020-12-31
PE 37.95
Dividend Yield 2.12
Payout Ratio: 80.340%
Date2019-12-31
PE 6.93
Dividend Yield 4.54
Payout Ratio: 31.478%
Date2018-12-31
PE 11.44
Dividend Yield 5.17
Payout Ratio: 59.109%
Date2017-12-31
PE 13.03
Dividend Yield 4.66
Payout Ratio: 60.757%
Date2016-12-31
PE 47.73
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-12-31
PE 46.46
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-06
Revenue 564,690,000
Net Income 543,987,000
EPS 1.61
Basic Shares 447,628,000
Diluted Shares 592,726,000
Report Link
Date2024-08-08
Revenue 537,267,000
Net Income 102,004,000
EPS 0.23
Basic Shares 451,020,000
Diluted Shares 596,912,000
Report Link
Date2024-05-09
Revenue 567,978,000
Net Income 4,778,000
EPS 0.0106
Basic Shares 448,623,000
Diluted Shares 597,479,000
Report Link
Date2024-02-15
Revenue 596,000,000
Net Income 494,340,000
EPS 1.11
Basic Shares 446,568,867
Diluted Shares 446,568,867
Report Link
Date2023-11-08
Revenue 536,313,000
Net Income 72,114,000
EPS 0.16
Basic Shares 448,439,000
Diluted Shares 601,138,000
Report Link
Date2023-08-08
Revenue 538,202,000
Net Income 227,625,000
EPS 0.51
Basic Shares 450,405,000
Diluted Shares 605,860,000
Report Link
Date2023-05-09
Revenue 683,971,000
Net Income 340,755,000
EPS 0.76
Basic Shares 445,612,000
Diluted Shares 607,251,000
Report Link
Date2023-02-15
Revenue 565,748,000
Net Income -610,169,000
EPS -1.38
Basic Shares 443,166,000
Diluted Shares 443,166,000
Report Link
Date2022-11-08
Revenue 573,463,000
Net Income 217,832,000
EPS 0.36
Basic Shares 607,226,000
Diluted Shares 607,226,000
Report Link
Date2022-08-04
Revenue 535,955,000
Net Income 304,504,000
EPS 0.5
Basic Shares 607,214,000
Diluted Shares 607,214,000
Report Link
Date2022-05-05
Revenue 562,049,000
Net Income -39,874,000
EPS -0.0657
Basic Shares 607,201,000
Diluted Shares 607,201,000
Report Link
Date2022-02-15
Revenue 575,700,000
Net Income 7,904,000
EPS 0.0156
Basic Shares 428,230,000
Diluted Shares 607,174,000
Report Link
Date2021-11-10
Revenue 585,773,000
Net Income 101,929,000
EPS 0.24
Basic Shares 428,230,000
Diluted Shares 607,174,000
Report Link
Date2021-08-11
Revenue 554,963,000
Net Income 440,776,000
EPS 1.08
Basic Shares 409,344,000
Diluted Shares 607,163,000
Report Link
Date2021-05-11
Revenue 573,027,000
Net Income 69,119,000
EPS 0.18
Basic Shares 389,760,000
Diluted Shares 607,148,000
Report Link
Date2021-02-24
Revenue 571,000,000
Net Income 171,000,000
EPS 0.44
Basic Shares 388,135,000
Diluted Shares 388,135,000
Report Link
Date2020-11-12
Revenue 539,000,000
Net Income 291,000,000
EPS 0.79
Basic Shares 369,999,000
Diluted Shares 370,002,000
Report Link
Date2020-08-12
Revenue 510,932,000
Net Income 442,074,000
EPS 0.09
Basic Shares 353,979,000
Diluted Shares 353,980,000
Report Link
Date2020-03-31
Revenue 500,879,000
Net Income 71,240,000
EPS 0.2
Basic Shares 350,554,830
Diluted Shares 350,554,830
Report Link
Date2019-12-31
Revenue 457,486,000
Net Income 1,420,396,000
EPS 4.01
Basic Shares 354,175,555
Diluted Shares 354,175,555
Report Link
Date2019-09-30
Revenue 464,277,000
Net Income 408,982,000
EPS 1.15
Basic Shares 354,175,555
Diluted Shares 354,175,555
Report Link
Date2019-06-30
Revenue 457,608,000
Net Income 151,713,000
EPS 0.43
Basic Shares 354,175,555
Diluted Shares 354,175,555
Report Link
Date2019-03-31
Revenue 434,883,000
Net Income 367,444,000
EPS 1.04
Basic Shares 354,175,555
Diluted Shares 354,175,555
Report Link

Quarterly Ratios

Date2024-09-30
PE 5.82
Dividend Yield 0.74
Payout Ratio: 17.291%
Date2024-06-30
PE 28.95
Dividend Yield 0.80
Payout Ratio: 93.078%
Date2024-03-31
PE 701.85
Dividend Yield 0.70
Payout Ratio: 1963.269%
Date2023-12-31
PE 6.34
Dividend Yield 0.71
Payout Ratio: 18.072%
Date2023-09-30
PE 42.19
Dividend Yield 0.74
Payout Ratio: 124.457%
Date2023-06-30
PE 15.21
Dividend Yield 0.65
Payout Ratio: 39.805%
Date2023-03-31
PE 11.78
Dividend Yield 0.55
Payout Ratio: 26.011%
Date2022-12-31
PE -7.18
Dividend Yield 0.48
Payout Ratio: -13.800%
Date2022-09-30
PE 28.00
Dividend Yield 0.34
Payout Ratio: 38.474%
Date2022-06-30
PE 20.96
Dividend Yield 0.33
Payout Ratio: 27.274%
Date2022-03-31
PE -148.32
Dividend Yield 0.35
Payout Ratio: -206.307%
Date2021-12-31
PE 539.76
Dividend Yield 0.43
Payout Ratio: 931.212%
Date2021-09-30
PE 37.96
Dividend Yield 0.47
Payout Ratio: 71.635%
Date2021-06-30
PE 9.52
Dividend Yield 0.43
Payout Ratio: 16.467%
Date2021-03-31
PE 61.49
Dividend Yield 0.39
Payout Ratio: 95.463%
Date2020-12-31
PE 28.40
Dividend Yield 0.30
Payout Ratio: 33.918%
Date2020-09-30
PE 13.37
Dividend Yield 0.35
Payout Ratio: 18.900%
Date2020-06-30
PE 9.72
Dividend Yield 0.84
Payout Ratio: 32.478%
Date2020-03-31
PE 54.74
Dividend Yield 0.91
Payout Ratio: 199.012%
Date2019-12-31
PE 2.77
Dividend Yield 1.11
Payout Ratio: 12.337%
Date2019-09-30
PE 9.63
Dividend Yield 1.07
Payout Ratio: 41.075%
Date2019-06-30
PE 25.97
Dividend Yield 1.26
Payout Ratio: 130.760%
Date2019-03-31
PE 10.72
Dividend Yield 1.25
Payout Ratio: 53.796%

RSI:

56.90

Price:

$26.22

Market Cap:

11,649,598,440

EPS TTM:

2.96

PE Ratio:

10.25

PEPSG:

0.5773

Fwd PE:

5.92

Volume:

2,276,187

2 Year Price Change

0.611

Index 2 Year Price Change

1.497

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: